Different Chemotherapy Regimens in the Management of Advanced or Metastatic Urothelial Cancer: a Bayesian Network Meta-Analysis of Randomized Controlled Trials

Background/Aims: Urothelial cancer (UC) as a chemotherapy-sensitive tumor, has achieved remarkable progresses in therapeutic paradigm, particularly in the advanced/metastatic stages. However, both clinicians and patients are confused when it comes to choosing the optimal chemotherapy. Hence, this ar...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cellular physiology and biochemistry 2018-01, Vol.50 (1), p.1-14
Hauptverfasser:	Wang, Yi, Xu, Lingyan, Meng, Xianghu, Qin, Zhiqiang, Wang, Yamin, Chen, Chen, Wang, Yichun, Zhou, Xiang, Zhang, Qijie, Xia, Jiadong, Song, Ninghong
Format:	Artikel
Sprache:	eng
Schlagworte:	Advanced/metastatic urothelial carcinoma Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bayes Theorem Bias Bladder Bladder cancer Blood Platelet Disorders - etiology Cancer therapies Chemotherapy Cisplatin - administration & dosage Clinical outcomes Clinical trials Confidence intervals Databases, Factual Deoxycytidine - administration & dosage Deoxycytidine - analogs & derivatives Disease-Free Survival Doxorubicin - administration & dosage Evidence-based medicine Humans Inhibitor drugs Meta-analysis Metastasis Neoplasm Staging Network meta-analysis Original Paper Paclitaxel - administration & dosage Randomized controlled trials Randomized Controlled Trials as Topic Response rates Software Survival Rate Targeted cancer therapy Toxicity Urologic Neoplasms - drug therapy Urologic Neoplasms - mortality Urologic Neoplasms - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!